Cofrancesco et al., 1981 - Google Patents
GAGs-Potentiated Inhibition of Thrombin, Factor Xa and Plasmin in Plasma and in a Purified System Containing Antithrombin III–Correlation with Total Charge DensityCofrancesco et al., 1981
- Document ID
- 15366770569864759953
- Author
- Cofrancesco E
- Vigo A
- Pogliani E
- Publication year
- Publication venue
- Thrombosis and Haemostasis
External Links
Snippet
The ability of heparin and related glycosaminoglycans (GAGs) to accelerate the inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III (At III) was studied using chromogenic peptide substrate assays There was a good …
- 210000002381 Plasma 0 title abstract description 39
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Andersson et al. | Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma | |
| Ofosu et al. | Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate | |
| Nagase et al. | Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III-and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin | |
| Grauffel et al. | New natural polysaccharides with potent antithrombic activity: fucans from brown algae | |
| Preissner et al. | Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism | |
| Ofosu et al. | The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate | |
| Suzuki et al. | Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka | |
| Yamagishi et al. | Purification and biological property of heparin cofactor II: Activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans | |
| Vijayagopal et al. | Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta | |
| Soria et al. | Anticoagulant activities of a pentosane polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin | |
| Scully et al. | Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54) | |
| Cofrancsco et al. | Correlation of sulfate content and degree of carboxylation of heparin and related glycosaminoglycans with anticomplement activity. Relationships to the anticoagulant and platelet-aggregating activities | |
| Ofosu et al. | The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor | |
| Ofosu et al. | Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma | |
| Hubbard et al. | Anticoagulant properties in vitro of heparan sulphates | |
| Scully et al. | Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation | |
| Kindness et al. | Effect of polyanetholesulphonic acid and xylan sulphate on antithrombin III activity | |
| Cofrancesco et al. | GAGs-Potentiated Inhibition of Thrombin, Factor Xa and Plasmin in Plasma and in a Purified System Containing Antithrombin III–Correlation with Total Charge Density | |
| Gallistl et al. | Thrombin-hirudin complex formation, thrombin-antithrombin III complex formation, and thrombin generation after intrinsic activation of plasma | |
| Dryjski et al. | Effect of glycosaminoglycans and antithrombin III on uptake and inhibition of thrombin by the vascular wall | |
| Ofosu et al. | Further studies on the mechanisms for the antithrombotic effects of sulfated polysaccharides in rabbits | |
| Schoen et al. | The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III | |
| Walenga et al. | Laboratory assays for the evaluation of recombinant hirudin | |
| MacGregor et al. | Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III | |
| Cavari et al. | Endogenous heparinase-sensitive anticoagulant activity in human plasma |